Inhibitory effects of lectins and lymphocyte mitogens on murine lymphomas and myelomas.
D000818:Animals; D002460:Cell Line; D003208:Concanavalin A / Q000494:pharmacology*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005688:Galactosamine / Q000494:pharmacology; D005690:Galactose / Q000494:pharmacology; D037102:Lectins / Q000494:pharmacology*; D007951:Leukemia, Myeloid / Q000378:metabolism*; D008070:Lipopolysaccharides; D008223:Lymphoma / Q000378:metabolism; D008358:Mannose / Q000494:pharmacology; D008759:Methylglycosides / Q000494:pharmacology; D051379:Mice; D008934:Mitogens / Q000494:pharmacology*; D009101:Multiple Myeloma / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000378:metabolism; D011135:Polysaccharides, Bacterial / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012276:Ricin / Q000494:pharmacology; D012485:Salmonella typhi; D013601:T-Lymphocytes / Q000187:drug effects
D004273:DNA, Neoplasm; D037102:Lectins; D008070:Lipopolysaccharides; D008759:Methylglycosides; D008934:Mitogens; D011135:Polysaccharides, Bacterial; D012334:RNA, Neoplasm; D003208:Concanavalin A; D005688:Galactosamine; D012276:Ricin; D008358:Mannose; D005690:Galactose